Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

9529	Companies
187479	Keywords
119514	Articles
100217	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 12/10/2025 at 00:05, 5 days 19 hours ago

Onco-Innovations Leads Precision Oncology Forum for Future Cancer Care

Cancer Care Precision Oncology Global Health Onco-Innovations Data Innovation
PRESS RELEASE

published on 12/10/2025 at 00:00, 5 days 19 hours ago

Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care
Onco-Innovations completes fourth session of Colorectal Cancer Canada's Catalysts Series focused on precision oncology and data-driven innovation, with key industry leaders participating in discussions on advancing national progress

Precision Oncology Onco-Innovations Colorectal Cancer Canada Data-driven Innovation National Progress
BRIEF

published on 12/07/2025 at 09:05, 8 days 10 hours ago

Onco-Innovations Plans Nasdaq Cross-listing and Possible Equity Offering

Equity Financing Cancer Research Investment Bank Onco-Innovations Nasdaq Cross-listing
PRESS RELEASE

published on 12/07/2025 at 09:00, 8 days 10 hours ago

Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Onco-Innovations engages U.S. investment bank for potential Nasdaq cross-listing and equity financing, part of long-term corporate development strategy

Equity Financing Nasdaq Investment Bank Onco-Innovations Cross-listing
BRIEF

published on 11/25/2025 at 22:35, 19 days 20 hours ago

Onco-Innovations Engages in University of Alberta's Innovation Awards

Cancer Research Innovation Awards Onco-Innovations PNKP Technology University Of Alberta
PRESS RELEASE

published on 11/25/2025 at 22:30, 19 days 20 hours ago

Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
Onco-Innovations recognized at University of Alberta's 2025 Innovation Awards for advancing oncology innovation and commercializing PNKP Inhibitor Technology from university research

Innovation Awards Cancer Therapeutics Onco-Innovations University Of Alberta PNKP Inhibitor Technology
BRIEF

published on 11/21/2025 at 01:35, 24 days 17 hours ago

Onco-Innovations Advances PNKP Inhibitor Scale-Up with Dalton Partnership

Cancer Treatment Clinical Studies Dalton Pharma Services PNKP Inhibitor Manufacturing Optimization
PRESS RELEASE

published on 11/21/2025 at 01:30, 24 days 17 hours ago

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
Onco-Innovations partners with Dalton Pharma Services for A83B4C63 manufacturing optimization and scale-up activities, aiming for future clinical material production

Onco-Innovations Dalton Pharma Services Manufacturing Optimization Scale-up Activities Clinical Material Production
BRIEF

published on 11/19/2025 at 00:05, 26 days 19 hours ago

Onco-Innovations and Kuano Collaborate on PNKP Inhibitor Development

AI In Drug Discovery Onco-Innovations PNKP Inhibitor Kuano Quantum Analytics
PRESS RELEASE

published on 11/19/2025 at 00:00, 26 days 19 hours ago

Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
Onco-Innovations partners with Kuano Ltd. to accelerate development of PNKP Inhibitor Technology, leveraging quantum analytics for cancer therapeutics. Details on advanced collaboration

Cancer Therapeutics Onco-Innovations Quantum Analytics Kuano Ltd. PNKP Inhibitor Technology

Accesswire

Published on 12/15/2025 at 18:15, 56 minutes ago

Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand
Published on 12/15/2025 at 16:35, 2 hours 36 minutes ago

Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 4 hours 11 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 4 hours 11 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 4 hours 41 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 18:15, 56 minutes ago

Results of EQT’s mandatory simplified cash tender offer for Waga Energy’s remaining shares
Published on 12/15/2025 at 18:07, 1 hour 3 minutes ago

POS-Transaction in Own Shares
Published on 12/15/2025 at 18:00, 1 hour 11 minutes ago

LIGHTON: Adjustment of ARR target for FY 2025
Published on 12/15/2025 at 17:45, 1 hour 26 minutes ago

EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 8 December 2025
Published on 12/15/2025 at 17:38, 1 hour 32 minutes ago

Stabilus SE approves share buyback program with a volume of up to €20 million

Les Echos

Published on 12/15/2025 at 18:30, 41 minutes ago

MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 1 hour 6 minutes ago

Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 1 hour 25 minutes ago

ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
Published on 12/15/2025 at 17:40, 1 hour 31 minutes ago

LISI joins the SBF 120 and CAC Mid 60 indices
Published on 12/15/2025 at 17:35, 1 hour 36 minutes ago

DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025

View all LES ECHOS COMFI WIRE